Form D · Investing

NSC Biotech Venture Fund I LLC

New York, NY · CIK 0001635884

Offering snapshot reported Mar 9, 2015 · SEC filing

Reported sold
$10M
Offering amount: $10M
Investors reported
88
Form D · investor count
Minimum accepted
$25K
Reported outside-investor minimum
First sale
Feb 27, 2015
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 9, 2015Initial$10,000,000No comparison88SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$800K
Finders' fees
$0
Form D file number
021-235439

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
National Securities Corporation7569N/A

Source: Form D, filed Mar 9, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

NSC BIOTECH OPPORTUNITIES QP FUND, LLC

Investment adviser: NATIONAL PRIVATE SHARES, INC.

Gross asset value
$17M
Beneficial owners
84
ADV minimum commitment
$25K

Reported in Form ADV on Nov 4, 2019. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator VENTURE BACK OFFICE, INC. CARY, North Carolina, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor WITHUMSMITH & BROWN, PC MORRISTOWN, New Jersey, United States
Custodian MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED SAN FRANCISCO, California, United States Related to adviser: No
Custodian SIGNATURE BANK NEW YORK, New York, United States Related to adviser: No
Marketer NATIONAL SECURITIES CORPORATION NEW YORK, New York, United States Related to adviser: Yes
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
Yes

WITHUMSMITH & BROWN, PC
PCAOB 100

MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED
SEC 8-7221

SIGNATURE BANK
LEI 13-4149421

NATIONAL SECURITIES CORPORATION
CRD 7569 · SEC 8-164

Filing source

Form ADV 1354207 · Nov 4, 2019 · Schedule D 7.B.(1), fund 805-6129429278

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Mark Goldwasser Executive
Michael Anthony Mullen Executive

Issuer details

Industry: Investing (See others in industry)

Address:
410 Park Avenue, 14 Th Floor
New York, NY, 10022